Olaf Hardt

Company: Miltenyi Biotec

Job title: Senior Manager, Research and Development

Seminars:

Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy 9:30 am

Miltenyi Biotec presents the MACSima Ultra-high content imaging platform Learn how MICS technology enables you to visualize hundreds of markers from fixed tissue to lift your sample analysis to the next level See a comprehensive workflow for the identification of new target candidatesRead more

day: Day Two